|
Session 194-Poster Abstracts
Insights into Post-exposure Prophylaxis
Wednesday, 2-4 pm; Poster Hall |
| 956 |
An Open Randomized Multicenter Clinical Trial Comparing Zidovudine/Lamivudine plus Lopinavir/Ritonavir or plus Atazanavir Used as Post-exposure Prophylaxis for HIV Infection
V Diaz–Brito1, A León1, H Knobel2, J Peraire3, P Domingo4, B Clotet5, D Dalmau6, M de la Prada1, J Gatell1, Felipe García*1, and for the DATEMPEP Study Group
1Hosp Clin, Univ of Barcelona, Spain; 2Hosp del Mar, Barcelona, Spain; 3Hosp Joan XXIII, Tarragona, Spain; 4Hosp de Sant Pau, Barcelona, Spain; 5Hosp Germans Trias i Pujol, Badalona, Spain; and 6Hosp Mutua de Terrassa, Barcelona, Spain |
| 957 |
Use and Sharing of Antiretroviral Medications for Pre- and Post-exposure Prophylaxis to Prevent Sexual Transmission of HIV among High-risk, Substance-using Men Who Have Sex with Men in 4 US Cities
Gordon Mansergh*1, G Colfax2, D McKirnan3, B Koblin4, S Flores1, S Hudson5, and the Project MIX Study Group
1CDC, Atlanta, GA, US; 2San Francisco Dept of Publ Hlth, CA, US; 3Univ of Illinois at Chicago, US; 4New York Blood Ctr, NY, US; and 5Hlth Res Assn, Los Angeles, CA, US |
958
 |
Characteristics of and HIV Seroconversion among Patients Receiving Non-occupational HIV Post-Exposure Prophylaxis in a Sexually Transmitted Disease Clinic: San Francisco, 2007 to 2009
Paul Adamson*, J Marcus, S Pipkin, S Scheer, K Bernstein, and S Philip
San Francisco Dept of Publ Hlth, CA, US |
|
